APA (7th ed.) Citation

Ghebeh, H., Al-Sayed, A., Eiada, R., Cabangon, L., Ajarim, D., Suleman, K., . . . Al-Tweigeri, T. (2021). Weekly Paclitaxel given concurrently with Durvalumab has a favorable safety profile in triple-negative metastatic breast cancer. Nature Portfolio.

Chicago Style (17th ed.) Citation

Ghebeh, Hazem, Adher Al-Sayed, Riham Eiada, Leilani Cabangon, Dahish Ajarim, Kausar Suleman, Asma Tulbah, and Taher Al-Tweigeri. Weekly Paclitaxel Given Concurrently with Durvalumab Has a Favorable Safety Profile in Triple-negative Metastatic Breast Cancer. Nature Portfolio, 2021.

MLA (8th ed.) Citation

Ghebeh, Hazem, et al. Weekly Paclitaxel Given Concurrently with Durvalumab Has a Favorable Safety Profile in Triple-negative Metastatic Breast Cancer. Nature Portfolio, 2021.